Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1143380

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1143380

Global Thoracolumbar Spine Devices Market - 2022-2029

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

Thoracolumbar Spine Devices Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 7.9% during the forecast period (2022-2029).

Thoracolumbar fractures are associated with disruption of the ligamentous complexes. These are breakages in the spinal column's vertebrae in the thoracic and lumbar region, which may result in instability or compression of neural structures. The thoracolumbar spine devices are used in this region to provide steady support to the spine and avoid bending of the thoracic spine. These devices treat spinal stenosis, spinal instability or scoliosis, degenerative disc disease (DDD), disc herniation, prolapsed intervertebral disc, and excessive kyphosis, among others.

Market Dynamics

The thoracolumbar spine devices market is growing due to the rising incidence of spinal disorders such as spinal stenosis, vertebral fracture, degenerative disc disease, excessive kyphosis, growing geriatric population and others.

The rising need for thoracolumbar spine devices and advancements in thoracolumbar spine devices fuel the global market growth.

The increasing number of spinal injury surgeries cases because of accidents and trauma is pushing the market growth, such as every year, approx. 250,00-500,000 people have spinal cord injuries, mostly because of road traffic crashes, falls or violence. For instance, world health organization data indicates that over 1.3 million people die yearly from road accident emergencies, and nearly 20-50 million globally suffer from non-fatal injuries. The CDC statistics on non-fatal injuries in 2020 show that around 2,885,545 ambulatory cases were of road accidents. In addition, NIH states that Hyperkyphosis increases with age, especially after the age of 40, and the prevalence is about 20% to 40% in adults 60 years or older; therefore, the rising geriatric population is fueling the global market growth, for instance, U.S. Census, around 727 million people, were aged 65 and over in 2020, and will 1.5 billion by 2050.

The high cost will hamper the global market growth.

The high cost of spinal surgery and thoracolumbar spine devices will hamper the global market growth. For instance, a single pedicle screw costs about $400-$1843, and an anterior cervical plate costs approx. $540-$2388, and s spinal surgery on average costs over $25000.

Industry Analysis

The global thoracolumbar spine devices market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, Etc.

Segment Analysis

The implants segment is predicted to dominate the global market during the forecast period (2022-2029).

Among these, the implants segment accounted for the largest market share in 2021 and is expected to dominate the market throughout the forecast period (2022-2029). Owing to the advancements in thoracolumbar spinal implants and market developments. For instance, on May 5, 2020, NuVasive, Inc., launched the Modulus XLIF Dual Sided Plate and the receipt of 510(k) clearances from the U.S. Food and Drug Administration (FDA) for Modulus ALIF and Cohere TLIF-O and thereby expanding its Advanced Materials Science (AMS) implant portfolio. Furthermore, the use of shape-memory alloys, sometimes referred to as smart metals that remember their shape at a specific temperature and return to that shape when the temperature is reached; examples of a few are the U.S. Food and Drug Administration (FDA) cleared OSSpine (DePuy Synthes) and 4Fusion (Stryker Corp.). Moreover, the augmentation of 3D printers allows flexible designing and creating of new geometries for the production of the implants.

Geographical Analysis

North America is estimated to subjugate the global thoracolumbar spine devices market.

North America is dominating the global thoracolumbar spine devices market, accounting for the largest market share in 2021, owing to the growing expansion of the U.S. healthcare industry in the emerging economies that supports the growth of the surgical procedures market, rising incidence of spinal diseases, and increasing technological development in thoracolumbar spine devices by major manufacturers. According to the Centers for Medicare & Medicaid Services, the U.S. healthcare expenditure grew 9.7% to $4.1 trillion in 2020, or $12,530 per person, and accounted for 19.7% of the Gross Domestic Product (GDP). Furthermore, North America has around 18380 Orthopedic surgeons registered, which fuels the region's dominance over the global market. Moreover, as per the National Spinal Cord Injury Statistical Center, in 2021 population size in the United States was estimated to be about 333 million people, and according to the most recent estimate, the annual incidence of traumatic spinal cord injury (SCI) is approximately 54 cases per one million people in the United States, which equals about 18,000 new SCI cases each year.

Competitive Landscape

The thoracolumbar spine devices market is highly competitive with the presence of a large number of players, including Depuy Synthes, Medtronic Plc., B. Braun Melsungen AG, Alphatec Holdings, Inc., Globus Medical, Inc., Exactech, Inc, Stryker Corporation, Orthofix International N.V, NuVasive, Inc., and Zimmer Biomet. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations contributing to the growth of the thoracolumbar spine devices market globally. For instance, on August 16, 2021, Globus Medical received FDA 510(k) Clearance for Excelsius3D, an intelligent intraoperative 3-in-1 imaging platform, the latest addition to the Global Medical portfolio. Also, AUG 30, 2022, Medtronic acquired Affera.

Medtronic, Plc.

Overview:

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio:

Medtronic plc's product portfolio for thoracolumbar spine devices has Mazor X Stealth Edition robotic guidance platform, Adaptix interbody system, CD Horizon ModuLeX 5.5 spinal system.

The global thoracolumbar spine devices market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Product Code: DMMD2079

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations and Developments
      • 4.1.1.2. The Growing Need for Thoracolumbar Spine Devices
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. Spine Biologics
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Implants
  • 7.4. Instrumentation
  • 7.5. Others

8. By Procedure

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Segment
    • 8.1.2. Market Attractiveness Index, By Procedure Segment
  • 8.2. Minimally Invasive Surgery (MIS)
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Retractors
  • 8.4. Posterior Stabilization Device
  • 8.5. Others

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material Segment
    • 9.1.2. Market Attractiveness Index, By Material Segment
  • 9.2. Stainless Steel
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Titanium
  • 9.4. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Specialized Neurosurgery Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Medtronic Plc
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Depuy Synthes
  • 13.3. B. Braun Melsungen AG
  • 13.4. Alphatec Holdings, Inc.
  • 13.5. Globus Medical, Inc.
  • 13.6. Exactech, Inc
  • 13.7. Stryker Corporation
  • 13.8. Orthofix International N.V
  • 13.9. NuVasive, Inc.
  • 13.10. Zimmer Biomet

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!